MRI-Guided Neurosurgical Ablation Market Size, Share & Trends Analysis Report 2024-2032
Description
The Global MRI-Guided Neurosurgical Ablation Market Size accounted for USD 628.9 Million in 2023 and is estimated to achieve a market size of USD 1,166.7 Million by 2032 growing at a CAGR of 7.2% from 2024 to 2032.
The MRI-guided neurosurgical ablation market represents a rapidly evolving sector within the field of medical technology, combining advanced imaging techniques with therapeutic interventions to treat various neurological conditions. Neurosurgical ablation refers to the process of removing or destroying abnormal brain tissue, such as tumors or other diseased areas, using targeted energy sources such as radiofrequency, laser, or focused ultrasound. MRI-guided neurosurgical ablation enhances the precision and effectiveness of these procedures by employing magnetic resonance imaging (MRI) to visualize the brain in real time, allowing for optimal targeting and minimal damage to healthy tissue. This abstract explores the key market drivers, current trends, challenges, and future growth opportunities in the MRI-guided neurosurgical ablation industry.
The primary market drivers for MRI-guided neurosurgical ablation are the rising prevalence of neurological disorders, technological advancements in MRI and ablation techniques, and the increasing demand for minimally invasive surgical procedures. Neurological conditions such as brain tumors, epilepsy, Parkinson's disease, and arteriovenous malformations (AVMs) are becoming more prevalent globally, particularly with an aging population and improvements in diagnostic capabilities that allow for earlier detection. The demand for effective treatments for these conditions has spurred growth in the field of neurosurgery, with MRI-guided ablation emerging as a promising technique for non-invasive or minimally invasive intervention.
MRI-Guided Neurosurgical Ablation Market Segmentation
The worldwide market for MRI-guided neurosurgical ablation is split based on product, end use, and geography.
MRI-Guided Neurosurgical Ablation Market By Product
Accessories
MRI-Guided Laser Ablation Systems
MRI-Guided Focused Ultrasound Systems
MRI-Guided Radiofrequency Ablation Systems
MRI-Guided Neurosurgical Ablation Market By End Use
Clinics
Ambulatory Surgical Centers
Hospitals
MRI-Guided Neurosurgical Ablation Market Regional Outlook
North America
U.S.
Canada
Europe
U.K.
Germany
France
Spain
Rest of Europe
Asia-Pacific
India
Japan
China
Australia
South Korea
Rest of Asia-Pacific
Latin America
Brazil
Mexico
Rest of Latin America
The Middle East & Africa
South Africa
GCC Countries
Rest of the Middle East & Africa (ME&A)
MRI-Guided Neurosurgical Ablation Market Players
Some of the top MRI-guided neurosurgical ablation companies offered in our report include Hitachi Medical Systems, AngioDynamics, Varian Medical Systems, Abbott Laboratories, MRI Interventions, Inc., Boston Scientific Corporation, MR Solutions, Monteris Medical, InSightec Ltd., Medtronic, and Elekta AB.
The MRI-guided neurosurgical ablation market represents a rapidly evolving sector within the field of medical technology, combining advanced imaging techniques with therapeutic interventions to treat various neurological conditions. Neurosurgical ablation refers to the process of removing or destroying abnormal brain tissue, such as tumors or other diseased areas, using targeted energy sources such as radiofrequency, laser, or focused ultrasound. MRI-guided neurosurgical ablation enhances the precision and effectiveness of these procedures by employing magnetic resonance imaging (MRI) to visualize the brain in real time, allowing for optimal targeting and minimal damage to healthy tissue. This abstract explores the key market drivers, current trends, challenges, and future growth opportunities in the MRI-guided neurosurgical ablation industry.
The primary market drivers for MRI-guided neurosurgical ablation are the rising prevalence of neurological disorders, technological advancements in MRI and ablation techniques, and the increasing demand for minimally invasive surgical procedures. Neurological conditions such as brain tumors, epilepsy, Parkinson's disease, and arteriovenous malformations (AVMs) are becoming more prevalent globally, particularly with an aging population and improvements in diagnostic capabilities that allow for earlier detection. The demand for effective treatments for these conditions has spurred growth in the field of neurosurgery, with MRI-guided ablation emerging as a promising technique for non-invasive or minimally invasive intervention.
MRI-Guided Neurosurgical Ablation Market Segmentation
The worldwide market for MRI-guided neurosurgical ablation is split based on product, end use, and geography.
MRI-Guided Neurosurgical Ablation Market By Product
Accessories
MRI-Guided Laser Ablation Systems
MRI-Guided Focused Ultrasound Systems
MRI-Guided Radiofrequency Ablation Systems
MRI-Guided Neurosurgical Ablation Market By End Use
Clinics
Ambulatory Surgical Centers
Hospitals
MRI-Guided Neurosurgical Ablation Market Regional Outlook
North America
U.S.
Canada
Europe
U.K.
Germany
France
Spain
Rest of Europe
Asia-Pacific
India
Japan
China
Australia
South Korea
Rest of Asia-Pacific
Latin America
Brazil
Mexico
Rest of Latin America
The Middle East & Africa
South Africa
GCC Countries
Rest of the Middle East & Africa (ME&A)
MRI-Guided Neurosurgical Ablation Market Players
Some of the top MRI-guided neurosurgical ablation companies offered in our report include Hitachi Medical Systems, AngioDynamics, Varian Medical Systems, Abbott Laboratories, MRI Interventions, Inc., Boston Scientific Corporation, MR Solutions, Monteris Medical, InSightec Ltd., Medtronic, and Elekta AB.
Table of Contents
250 Pages
- CHAPTER 1. Industry Overview of MRI-Guided Neurosurgical Ablation Market
- 1.1. Definition and Scope
- 1.1.1. Definition of MRI-Guided Neurosurgical Ablation
- 1.1.2. Market Segmentation
- 1.1.3. Years Considered for the Study
- 1.1.4. Assumptions and Acronyms Used
- 1.1.4.1. Market Assumptions and Market Forecast
- 1.1.4.2. Acronyms Used in Global MRI-Guided Neurosurgical Ablation Market
- 1.2. Summary
- 1.2.1. Executive Summary
- 1.2.2. MRI-Guided Neurosurgical Ablation Market By Product
- 1.2.3. MRI-Guided Neurosurgical Ablation Market By End Use
- 1.2.4. MRI-Guided Neurosurgical Ablation Market By Region
- CHAPTER 2. Research Approach
- 2.1. Methodology
- 2.1.1. Research Programs
- 2.1.2. Market Size Estimation
- 2.1.3. Market Breakdown and Data Triangulation
- 2.2. Data Source
- 2.2.1. Secondary Sources
- 2.2.2. Primary Sources
- CHAPTER 3. Market Dynamics And Competition Analysis
- 3.1. Market Drivers
- 3.1.1. Driver 1
- 3.1.2. Driver 2
- 3.2. Restraints and Challenges
- 3.2.1. Restraint 1
- 3.2.2. Restraint 2
- 3.3. Growth Opportunities
- 3.3.1. Opportunity 1
- 3.3.2. Opportunity 2
- 3.4. Porter’s Five Forces Analysis
- 3.4.1. Bargaining Power of Suppliers
- 3.4.2. Bargaining Power of Buyers
- 3.4.3. Threat of Substitute
- 3.4.4. Threat of New Entrants
- 3.4.5. Degree of Competition
- 3.5. Market Concentration Ratio and Market Maturity Analysis of MRI-Guided Neurosurgical Ablation Market
- 3.5.1. Go To Market Strategy
- 3.5.1.1. Introduction
- 3.5.1.2. Growth
- 3.5.1.3. Maturity
- 3.5.1.4. Saturation
- 3.5.1.5. Possible Development
- 3.6. Technological Roadmap for MRI-Guided Neurosurgical Ablation Market
- 3.7. Value Chain Analysis
- 3.7.1. List of Key Manufacturers
- 3.7.2. List of Customers
- 3.7.3. Level of Integration
- 3.8. Cost Structure Analysis
- 3.8.1. Price Trend of Key Raw Materials
- 3.8.2. Raw Material Suppliers
- 3.8.3. Proportion of Manufacturing Cost Structure
- 3.8.3.1. Raw Material
- 3.8.3.2. Labor Cost
- 3.8.3.3. Manufacturing Expense
- 3.9. Regulatory Compliance
- 3.10. Competitive Landscape, 2023
- 3.10.1. Player Positioning Analysis
- 3.10.2. Key Strategies Adopted By Leading Players
- CHAPTER 4. Manufacturing Plant Analysis
- 4.1. Manufacturing Plant Location and Establish Date of Major Manufacturers in 2023
- 4.2. R&D Status of Major Manufacturers in 2023
- CHAPTER 5. MRI-Guided Neurosurgical Ablation Market By Product
- 5.1. Introduction
- 5.2. MRI-Guided Neurosurgical Ablation Revenue By Product
- 5.2.1. MRI-Guided Neurosurgical Ablation Revenue (USD Million) and Forecast, By Product, 2020-2032
- 5.2.2. Accessories
- 5.2.2.1. Accessories Market Revenue (USD Million) and Growth Rate (%), 2020-2032
- 5.2.3. MRI-guided Laser Ablation Systems
- 5.2.3.1. MRI-guided Laser Ablation Systems Market Revenue (USD Million) and Growth Rate (%), 2020-2032
- 5.2.4. MRI-guided Focused Ultrasound Systems
- 5.2.4.1. MRI-guided Focused Ultrasound Systems Market Revenue (USD Million) and Growth Rate (%), 2020-2032
- 5.2.5. MRI-guided Radiofrequency Ablation Systems
- 5.2.5.1. MRI-guided Radiofrequency Ablation Systems Market Revenue (USD Million) and Growth Rate (%), 2020-2032
- CHAPTER 6. MRI-Guided Neurosurgical Ablation Market By End Use
- 6.1. Introduction
- 6.2. MRI-Guided Neurosurgical Ablation Revenue By End Use
- 6.2.1. MRI-Guided Neurosurgical Ablation Revenue (USD Million) and Forecast, By End Use, 2020-2032
- 6.2.2. Clinics
- 6.2.2.1. Clinics Market Revenue (USD Million) and Growth Rate (%), 2020-2032
- 6.2.3. Ambulatory Surgical Centers
- 6.2.3.1. Ambulatory Surgical Centers Market Revenue (USD Million) and Growth Rate (%), 2020-2032
- 6.2.4. Hospitals
- 6.2.4.1. Hospitals Market Revenue (USD Million) and Growth Rate (%), 2020-2032
- CHAPTER 7. North America MRI-Guided Neurosurgical Ablation Market By Country
- 7.1. North America MRI-Guided Neurosurgical Ablation Market Overview
- 7.2. U.S.
- 7.2.1. U.S. MRI-Guided Neurosurgical Ablation Revenue (USD Million) and Forecast By Product, 2020-2032
- 7.2.2. U.S. MRI-Guided Neurosurgical Ablation Revenue (USD Million) and Forecast By End Use, 2020-2032
- 7.3. Canada
- 7.3.1. Canada MRI-Guided Neurosurgical Ablation Revenue (USD Million) and Forecast By Product, 2020-2032
- 7.3.2. Canada MRI-Guided Neurosurgical Ablation Revenue (USD Million) and Forecast By End Use, 2020-2032
- 7.4. North America PEST Analysis
- CHAPTER 8. Europe MRI-Guided Neurosurgical Ablation Market By Country
- 8.1. Europe MRI-Guided Neurosurgical Ablation Market Overview
- 8.2. U.K.
- 8.2.1. U.K. MRI-Guided Neurosurgical Ablation Revenue (USD Million) and Forecast By Product, 2020-2032
- 8.2.2. U.K. MRI-Guided Neurosurgical Ablation Revenue (USD Million) and Forecast By End Use, 2020-2032
- 8.3. Germany
- 8.3.1. Germany MRI-Guided Neurosurgical Ablation Revenue (USD Million) and Forecast By Product, 2020-2032
- 8.3.2. Germany MRI-Guided Neurosurgical Ablation Revenue (USD Million) and Forecast By End Use, 2020-2032
- 8.4. France
- 8.4.1. France MRI-Guided Neurosurgical Ablation Revenue (USD Million) and Forecast By Product, 2020-2032
- 8.4.2. France MRI-Guided Neurosurgical Ablation Revenue (USD Million) and Forecast By End Use, 2020-2032
- 8.5. Spain
- 8.5.1. Spain MRI-Guided Neurosurgical Ablation Revenue (USD Million) and Forecast By Product, 2020-2032
- 8.5.2. Spain MRI-Guided Neurosurgical Ablation Revenue (USD Million) and Forecast By End Use, 2020-2032
- 8.6. Rest of Europe
- 8.6.1. Rest of Europe MRI-Guided Neurosurgical Ablation Revenue (USD Million) and Forecast By Product, 2020-2032
- 8.6.2. Rest of Europe MRI-Guided Neurosurgical Ablation Revenue (USD Million) and Forecast By End Use, 2020-2032
- 8.7. Europe PEST Analysis
- CHAPTER 9. Asia Pacific MRI-Guided Neurosurgical Ablation Market By Country
- 9.1. Asia Pacific MRI-Guided Neurosurgical Ablation Market Overview
- 9.2. China
- 9.2.1. China MRI-Guided Neurosurgical Ablation Revenue (USD Million) and Forecast By Product, 2020-2032
- 9.2.2. China MRI-Guided Neurosurgical Ablation Revenue (USD Million) and Forecast By End Use, 2020-2032
- 9.3. Japan
- 9.3.1. Japan MRI-Guided Neurosurgical Ablation Revenue (USD Million) and Forecast By Product, 2020-2032
- 9.3.2. Japan MRI-Guided Neurosurgical Ablation Revenue (USD Million) and Forecast By End Use, 2020-2032
- 9.4. India
- 9.4.1. India MRI-Guided Neurosurgical Ablation Revenue (USD Million) and Forecast By Product, 2020-2032
- 9.4.2. India MRI-Guided Neurosurgical Ablation Revenue (USD Million) and Forecast By End Use, 2020-2032
- 9.5. Australia
- 9.5.1. Australia MRI-Guided Neurosurgical Ablation Revenue (USD Million) and Forecast By Product, 2020-2032
- 9.5.2. Australia MRI-Guided Neurosurgical Ablation Revenue (USD Million) and Forecast By End Use, 2020-2032
- 9.6. South Korea
- 9.6.1. South Korea MRI-Guided Neurosurgical Ablation Revenue (USD Million) and Forecast By Product, 2020-2032
- 9.6.2. South Korea MRI-Guided Neurosurgical Ablation Revenue (USD Million) and Forecast By End Use, 2020-2032
- 9.7. Rest of Asia-Pacific
- 9.7.1. Rest of Asia-Pacific MRI-Guided Neurosurgical Ablation Revenue (USD Million) and Forecast By Product, 2020-2032
- 9.7.2. Rest of Asia-Pacific MRI-Guided Neurosurgical Ablation Revenue (USD Million) and Forecast By End Use, 2020-2032
- 9.8. Asia Pacific PEST Analysis
- CHAPTER 10. Latin America MRI-Guided Neurosurgical Ablation Market By Country
- 10.1. Latin America MRI-Guided Neurosurgical Ablation Market Overview
- 10.2. Brazil
- 10.2.1. Brazil MRI-Guided Neurosurgical Ablation Revenue (USD Million) and Forecast By Product, 2020-2032
- 10.2.2. Brazil MRI-Guided Neurosurgical Ablation Revenue (USD Million) and Forecast By End Use, 2020-2032
- 10.3. Mexico
- 10.3.1. Mexico MRI-Guided Neurosurgical Ablation Revenue (USD Million) and Forecast By Product, 2020-2032
- 10.3.2. Mexico MRI-Guided Neurosurgical Ablation Revenue (USD Million) and Forecast By End Use, 2020-2032
- 10.4. Rest of Latin America
- 10.4.1. Rest of Latin America MRI-Guided Neurosurgical Ablation Revenue (USD Million) and Forecast By Product, 2020-2032
- 10.4.2. Rest of Latin America MRI-Guided Neurosurgical Ablation Revenue (USD Million) and Forecast By End Use, 2020-2032
- 10.5. Latin America PEST Analysis
- CHAPTER 11. Middle East & Africa MRI-Guided Neurosurgical Ablation Market By Country
- 11.1. Middle East & Africa MRI-Guided Neurosurgical Ablation Market Overview
- 11.2. GCC
- 11.2.1. GCC MRI-Guided Neurosurgical Ablation Revenue (USD Million) and Forecast By Product, 2020-2032
- 11.2.2. GCC MRI-Guided Neurosurgical Ablation Revenue (USD Million) and Forecast By End Use, 2020-2032
- 11.3. South Africa
- 11.3.1. South Africa MRI-Guided Neurosurgical Ablation Revenue (USD Million) and Forecast By Product, 2020-2032
- 11.3.2. South Africa MRI-Guided Neurosurgical Ablation Revenue (USD Million) and Forecast By End Use, 2020-2032
- 11.4. Rest of Middle East & Africa
- 11.4.1. Rest of Middle East & Africa MRI-Guided Neurosurgical Ablation Revenue (USD Million) and Forecast By Product, 2020-2032
- 11.4.2. Rest of Middle East & Africa MRI-Guided Neurosurgical Ablation Revenue (USD Million) and Forecast By End Use, 2020-2032
- 11.5. Middle East & Africa PEST Analysis
- CHAPTER 12. Player Analysis Of MRI-Guided Neurosurgical Ablation Market
- 12.1. MRI-Guided Neurosurgical Ablation Market Company Share Analysis
- 12.2. Competition Matrix
- 12.2.1. Competitive Benchmarking of key players by price, presence, market share, and R&D investment
- 12.2.2. New Product Launches and Product Enhancements
- 12.2.3. Mergers And Acquisition In Global MRI-Guided Neurosurgical Ablation Market
- 12.2.4. Partnership, Joint Ventures and Strategic Alliances/ Sales Agreements
- CHAPTER 13. Company Profile
- 13.1. Hitachi Medical Systems
- 13.1.1. Company Snapshot
- 13.1.2. Business Overview
- 13.1.3. Financial Overview
- 13.1.3.1. Revenue (USD Million), 2023
- 13.1.3.2. Hitachi Medical Systems 2023 MRI-Guided Neurosurgical Ablation Business Regional Distribution
- 13.1.4. Product /Service and Specification
- 13.1.5. Recent Developments & Business Strategy
- 13.2. AngioDynamics
- 13.3. Varian Medical Systems
- 13.4. Abbott Laboratories
- 13.5. MRI Interventions, Inc.
- 13.6. Boston Scientific Corporation
- 13.7. MR Solutions
- 13.8. Monteris Medical
- 13.9. InSightec Ltd.
- 13.10. Medtronic
- 13.11. Elekta AB
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
